ERAMET (ERA.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ERA • FR0000131757

63 EUR
-5.05 (-7.42%)
Last: Feb 9, 2026, 03:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall ERA gets a fundamental rating of 2 out of 10. We evaluated ERA against 42 industry peers in the Metals & Mining industry. Both the profitability and financial health of ERA have multiple concerns. ERA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ERA has reported negative net income.
  • In the past year ERA has reported a negative cash flow from operations.
  • ERA had positive earnings in 4 of the past 5 years.
  • ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.58%, ERA is doing worse than 64.29% of the companies in the same industry.
  • With a Return On Equity value of -9.29%, ERA is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 0.84%, ERA is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for ERA is in line with the industry average of 7.74%.
  • The last Return On Invested Capital (0.84%) for ERA is well below the 3 year average (7.61%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • In the last couple of years the Profit Margin of ERA has declined.
  • With a Operating Margin value of 1.91%, ERA is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of ERA has declined.
  • The Gross Margin of ERA (68.15%) is better than 90.48% of its industry peers.
  • ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ERA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ERA has more shares outstanding
  • The number of shares outstanding for ERA has been increased compared to 5 years ago.
  • ERA has a better debt/assets ratio than last year.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.13, we must say that ERA is in the distress zone and has some risk of bankruptcy.
  • ERA's Altman-Z score of 1.13 is on the low side compared to the rest of the industry. ERA is outperformed by 73.81% of its industry peers.
  • A Debt/Equity ratio of 2.03 is on the high side and indicates that ERA has dependencies on debt financing.
  • ERA's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. ERA is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC0.08
WACC9.94%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • ERA's Current ratio of 1.54 is on the low side compared to the rest of the industry. ERA is outperformed by 71.43% of its industry peers.
  • ERA has a Quick Ratio of 1.06. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • ERA has a Quick ratio (1.06) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for ERA have decreased strongly by -219.63% in the last year.
  • The earnings per share for ERA have been decreasing by -64.00% on average. This is quite bad
  • ERA shows a decrease in Revenue. In the last year, the revenue decreased by -6.91%.
  • Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

  • Based on estimates for the next years, ERA will show a very negative growth in Earnings Per Share. The EPS will decrease by -25.91% on average per year.
  • The Revenue is expected to grow by 7.00% on average over the next years.
EPS Next Y-282.67%
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%
EPS Next 5YN/A
Revenue Next Year-0.95%
Revenue Next 2Y5.78%
Revenue Next 3Y7%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ERA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

  • ERA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.86
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

  • ERA's earnings are expected to decrease with -25.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • ERA has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.66, ERA pays a bit more dividend than its industry peers.
  • ERA's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • The earnings of ERA are negative and hence is the payout ratio. ERA will probably not be able to sustain this dividend level.
DP-44.33%
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

More info and screens

Find the best dividend stocksShow peers with best dividend

ERAMET

EPA:ERA (2/9/2026, 3:01:12 PM)

63

-5.05 (-7.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-30
Earnings (Next)02-18
Inst Owners15.34%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.81B
Revenue(TTM)2.88B
Net Income(TTM)-97.00M
Analysts52.73
Price Target61.51 (-2.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.2%
PT rev (3m)17.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)24.02%
EPS NY rev (3m)0.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 3.36
EV/EBITDA 16.86
EPS(TTM)-3.42
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexgc growth 3Y-56.22%
ROICexgc growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.13
F-Score2
WACC9.94%
ROIC/WACC0.08
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-282.67%
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year-0.95%
Revenue Next 2Y5.78%
Revenue Next 3Y7%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year8.9%
EBIT Next 3Y30.86%
EBIT Next 5YN/A
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A

ERAMET / ERA.PA FAQ

What is the fundamental rating for ERA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ERA.PA.


Can you provide the valuation status for ERAMET?

ChartMill assigns a valuation rating of 0 / 10 to ERAMET (ERA.PA). This can be considered as Overvalued.


Can you provide the profitability details for ERAMET?

ERAMET (ERA.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for ERA stock?

The dividend rating of ERAMET (ERA.PA) is 2 / 10 and the dividend payout ratio is -44.33%.